HomeXTLB • NASDAQ
add
X T L Biopharmaceuticals Ltd
Previous close
$2.58
Day range
$2.52 - $2.53
Year range
$0.75 - $4.99
Market cap
13.80M USD
Avg Volume
1.06M
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 200.00K | -11.11% |
Net income | -284.00K | 62.03% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 2.01M | -46.09% |
Total assets | 2.43M | -42.04% |
Total liabilities | 206.00K | 10.16% |
Total equity | 2.22M | — |
Shares outstanding | 544.91M | — |
Price to book | — | — |
Return on assets | -19.65% | — |
Return on capital | -21.18% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -284.00K | 62.03% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
1993
Headquarters
Website